Pricing Log in Create free account

Absci Corporation (ABSI) vs Kailera Therapeutics, Inc. (KLRA)

Absci Corporation and Kailera Therapeutics, Inc. are both Biotechnology companies. Absci Corporation and Kailera Therapeutics, Inc. are of similar size ($1.6B and $1.6B). Kailera Therapeutics, Inc. has the higher net margin (0.00% vs −7,756.4%) and the lower return on invested capital (−182.9% vs −174.7%). Across the 12 metrics below, Kailera Therapeutics, Inc. leads on 7 and Absci Corporation on 5.

Valuation

Metric ABSI KLRA Biotechnology median
P/E n/m n/m 10.60
P/S 1,024.93 n/m 9.40
P/B 6.50 1.63 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales 896.21 n/m 9.02
Earnings yield (7.87%) 661,008,480.09% (32.88%)
Free cash flow yield (6.80%) (19.39%) (23.13%)

Profitability

Metric ABSI KLRA Biotechnology median
Gross margin 100.00% — 68.51%
Operating margin (8,084.50%) 0.00% 0.00%
Net margin (7,756.37%) 0.00% 0.00%
Free cash flow margin (6,969.83%) 0.00% 0.00%
Return on equity (57.72%) (85.74%) (51.96%)
Return on assets (50.57%) (55.25%) (46.06%)
Return on invested capital (174.74%) (182.92%) 0.00%

Growth

Metric ABSI KLRA Biotechnology median
Revenue growth (TTM) (62.28%) — 6.76%
EPS growth (last fiscal year) 10.64% — 29.88%
Revenue growth, 5-year CAGR (10.14%) — 9.75%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric ABSI KLRA Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 10.63 21.84 4.97
Net debt to EBITDA 1.32 3.46 1.01

Dividend

Metric ABSI KLRA Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric ABSI KLRA Biotechnology median
Market cap 1.61b 1.58b 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack